Impact of the Delta variant on vaccine efficacy and response strategies-Reference-Cited by-同舟云学术

Impact of the Delta variant on vaccine efficacy and response strategies

Published:2021-09-09 Issue:10 Volume:20 Page:1201-1209
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Bian Lianlian,Gao Qiushuang,Gao Fan¹,Wang Qian¹,He Qian¹,Wu Xing¹,Mao Qunying¹,Xu Miao¹,Liang Zhenglun¹

Affiliation:

1. Division of Hepatitis and Enterovirus Virus Vaccines, National Institutes for Food and Drug Control, Beijing, China

Funder

National Key R&D Program of China

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2021.1976153

Reference59 articles.

1. WHO 2021. SARS-COV-2 weekly epidemiological update.

2. The paper 2021. WHO: the world is at the early stage of the third round of epidemic. [accessed 2021 Aug 14] https://www.thepaper.cn/newsDetail_forward_13594892

3. ECDC. 2021. SARS-COV-2 Delta variant now dominant in much of the European region and efforts must be reinforced to prevent transmission, warn WHO/Europe and ECDC. July 23.

4. Alpha, Beta, Delta, Gamma: What’s important to know about SARS-CoV-2 variants of concern?

5. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of COVID with Mycosis in General;Infectious Disorders - Drug Targets;2024-09

2. Handgrip strength as a prognostic factor for COVID-19 mortality among older adult patients admitted to the intensive care unit (ICU): a comparison Alpha (B.1.1.7) and Delta (B.1.617.2) variants;Scientific Reports;2024-08-27

3. Risk assessment of infection of COVID‐19 contacts based on scenario simulation;Risk Analysis;2024-07-29

4. Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination;Human Antibodies;2024-07-24

5. Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus;eLife;2024-05-07